# Chia-lipid-profile-meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/chia-lipid-profile-meta-analysis-evidence-review
Category: evidence-review
Summary: Chia-lipid-profile-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are system
Last reviewed: 2026-08-07
Reviewed by: Migaku Evidence Review
# Chia-lipid-profile-meta-analysis: What the Evidence Says

## Quick Answer

Chia-lipid-profile-meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Ketogenic diet–induced changes in adult lipid metabolism: a comprehensive systematic review and meta-regression of randomized controlled trials | systematic review | 1 | 2026-04-30 | 10.1186/s12872-026-05799-5 |
| Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review | preclinical study | 4 | 2026-04-05 | 10.7759/cureus.106497 |

## What The Sources Report

- Additional evidence indicates that the KD may be beneficial for treating nutrition-related conditions such as type 2 diabetes (T2DM), heart disease, cancer, and liver disease. [Zhao Juanjuan (2026); evidence level 1]
- Although KD is often considered to negatively affect lipid metabolism due to its high saturated fat content, there is also evidence suggesting the opposite. [Zhao Juanjuan (2026); evidence level 1]
- Polycystic ovary syndrome (PCOS) is among the most frequent endocrine disorders in women of reproductive age and is strongly associated with multiple cardiometabolic disturbances. [Muacevic Alexander (2026); evidence level 4]
- While these approaches can reduce symptoms, they mostly do not address the underlying endocrine or metabolic disturbances and may be associated with adverse effects, including gastrointestinal discomfort, weight gain, and fatigue. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For chia-lipid-profile-meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhao Juanjuan (2026). Ketogenic diet–induced changes in adult lipid metabolism: a comprehensive systematic review and meta-regression of randomized controlled trials. DOI: 10.1186/s12872-026-05799-5. PMCID: PMC13281555. PMID: 42056882. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13281555/
- Muacevic Alexander (2026). Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review. DOI: 10.7759/cureus.106497. PMCID: PMC13146035. PMID: 42099351. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13146035/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.